Director's Dealing • Sep 21, 2021
Director's Dealing
Open in ViewerOpens in native device viewer
Sopharma AD (the "Company") announces that pursuant to art. 3, para 26a and art. 19, para 1a from Regulation 596/2014 of the European Parliament and of the Council, it was notified by Mrs Rositsa Doneva, person closely associated with Mr Ognian Donev, Chairman of the Board of Directors that she, executed the following transactions related to shares in the Company:
| Date of the transaction |
Operation | Number of shares |
Unit price (BGN) |
|---|---|---|---|
| 20.09.2021 | Buy | 200 | 3,74 |
| 20.09.2021 | Buy | 300 | 3,74 |
| 20.09.2021 | Buy | 300 | 3,72 |
| 20.09.2021 | Buy | 300 | 3,72 |
| 20.09.2021 | Buy | 12 | 3,72 |
| 20.09.2021 | Buy | 300 | 3,72 |
| 20.09.2021 | Buy | 12 | 3,72 |
| 20.09.2021 | Buy | 488 | 3,72 |
| 20.09.2021 | Buy | 500 | 3,70 |
The transfer of the above-mentioned shares was executed on the Bulgarian Stock Exchange in Sofia (regulated market) by way of electronic trade.
Signatures of individuals authorized to represent the Company:
Ognian Donev
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.